Combining EGFR and MET Inhibition With Crizotinib in EGFR-mutated Lung Adenocarcinoma Harboring MET Amplification: A Brief Report

被引：4

作者：

Aubanel, Marjorie ^{[1
]}

Swalduz, Aurelie ^{[1
]}

Avrillon, Virginie ^{[1
]}

Doublet, Louis ^{[1
]}

Mastroianni, Benedicte ^{[1
]}

Neidhardt-Berard, Eve-Marie ^{[1
]}

Perol, Maurice ^{[1
]}

机构：

[1] Ctr Leon Berard, Dept Med Oncol, 28 Rue Laennec, F-69008 Lyon, France

来源：

CLINICAL LUNG CANCER | 2020年 / 21卷 / 06期

关键词：

Combination targeted therapies; EGFR TKI; Lung cancer; MET amplification; Resistance; NSCLC PATIENTS; CANCER; ERLOTINIB; COMBINATION; OSIMERTINIB; RESISTANCE; PATIENT;

D O I：

10.1016/j.cllc.2020.05.015

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

[No abstract available]

引用

页码：E601 / E606

页数：6

共 26 条

[21] Mechanisms of acquired resistance to first- and second-generation EGFR tyrosine kinase inhibitors [J].

Westover, D. ;

Zugazagoitia, J. ;

Cho, B. C. ;

Lovly, C. M. ;

Paz-Ares, L. .

ANNALS OF ONCOLOGY, 2018, 29 :I10-I19

[22] Phase Ib/II Study of Capmatinib (INC280) Plus Gefitinib After Failure of Epidermal Growth Factor Receptor (EGFR) Inhibitor Therapy in Patients With EGFR-Mutated, MET Factor-Dysregulated Non-Small-Cell Lung Cancer [J].

Wu, Yi-Long ;

Zhang, Li ;

Kim, Dong-Wan ;

Liu, Xiaoqing ;

Lee, Dae Ho ;

Yang, James Chih-Hsin ;

Ahn, Myung-Ju ;

Vansteenkiste, Johan F. ;

Su, Wu-Chou ;

Felip, Enriqueta ;

Chia, Vincent ;

Glaser, Sabine ;

Pultar, Philippe ;

Zhao, Sylvia ;

Peng, Bin ;

Akimov, Mikhail ;

Tan, Daniel S. W. .

JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (31) :3101-+

[23] Tepotinib plus gefitinib vs chemotherapy in MET-amplified EGFR-mutant non-small cell lung cancer (NSCLC): Predefined subgroup analysis of a Phase Ib/II study [J].

Yang, James Chih-Hsin ;

Zhou, Jianying ;

Kim, Dong-Wan ;

Ahmad, Azura Rozila ;

Soo, Ross Andrew ;

Bruns, Rolf ;

Straub, Josef ;

Johne, Andreas ;

Scheele, Juergen ;

Park, Keunchil ;

Wu, Yi-Long .

CANCER RESEARCH, 2019, 79 (13)

[24] Osimertinib in Pretreated T790M-Positive Advanced Non-Small-Cell Lung Cancer: AURA Study Phase II Extension Component [J].

Yang, James Chih-Hsin ;

Ahn, Myung-Ju ;

Kim, Dong-Wan ;

Ramalingam, Suresh S. ;

Sequist, Lecia V. ;

Su, Wu-Chou ;

Kim, Sang-We ;

Kim, Joo-Hang ;

Planchard, David ;

Felip, Enriqueta ;

Blackhall, Fiona ;

Haggstrom, Daniel ;

Yoh, Kiyotaka ;

Novello, Silvia ;

Gold, Kathryn ;

Hirashima, Tomonori ;

Lin, Chia-Chi ;

Mann, Helen ;

Cantarini, Mireille ;

Ghiorghiu, Serban ;

Janne, Pasi A. .

JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (12) :1288-+

[25]

York Emily R, 2017, J Thorac Oncol, V12, pe85, DOI 10.1016/j.jtho.2017.02.020

[26]

Yoshimura K, 2017, RESPIR MED CASE REP, V20, P160, DOI 10.1016/j.rmcr.2017.02.009

← 1 2 3 →